FREE-LIVING CLOSED-LOOP INSULIN DELIVERY FOR PATIENTS WITH TYPE 1 DIABETES: A LONG-TERM MULTI-CENTRE RANDOMIZED CONTROLLED TRIAL

Abstract

Closed loop technology for automating the delivery of insulin to patients with Type 1 diabetes has the potential to improve the lives of many with the disease. Though early prototypes are currently under evaluation in small studies, no studies have yet to date applied the technology in a large scale randomised trial. We propose to undertake such a study in order to demonstrate the utility of this technology and facilitate its eventual routine and widespread use in the community in the future.